Publication:
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network

Simple item page
dc.contributor.authorRose, Angela Mc
dc.contributor.authorPozo Sanchez, Francisco
dc.contributor.authorMartínez-Baz, Iván
dc.contributor.authorMazagatos, Clara
dc.contributor.authorBossuyt, Nathalie
dc.contributor.authorCauchi, John Paul
dc.contributor.authorPetrović, Goranka
dc.contributor.authorLoghin, Isabela I
dc.contributor.authorVaikutytė, Roberta
dc.contributor.authorBuda, Silke
dc.contributor.authorMachado, Ausenda
dc.contributor.authorDuffy, Róisín
dc.contributor.authorOroszi, Beatrix
dc.contributor.authorHoward, Jennifer
dc.contributor.authorEcheverria, Aitziber
dc.contributor.authorAndreu, Cristina
dc.contributor.authorBarbezange, Cyril
dc.contributor.authorDžiugytė, Aušra
dc.contributor.authorNonković, Diana
dc.contributor.authorPopescu, Corneliu-Petru
dc.contributor.authorMajauskaite, Fausta
dc.contributor.authorTolksdorf, Kristin
dc.contributor.authorGomez, Verónica
dc.contributor.authorDomegan, Lisa
dc.contributor.authorHorváth, Judit Krisztina
dc.contributor.authorCastilla, Jesús
dc.contributor.authorGarcía, Miriam
dc.contributor.authorDemuyser, Thomas
dc.contributor.authorBorg, Maria-Louise
dc.contributor.authorTabain, Irena
dc.contributor.authorLazar, Mihaela
dc.contributor.authorKubiliute, Ieva
dc.contributor.authorDürrwald, Ralf
dc.contributor.authorGuiomar, Raquel
dc.contributor.authorO'Donnell, Joan
dc.contributor.authorKristóf, Katalin
dc.contributor.authorNicolay, Nathalie
dc.contributor.authorBacci, Sabrina
dc.contributor.authorKissling, Esther
dc.contributor.authorEBIS SARI VE network team
dc.contributor.funderNational Research, Development and Innovation Office (Hungria)
dc.date.accessioned2024-03-22T11:17:45Z
dc.date.available2024-03-22T11:17:45Z
dc.date.issued2024-02
dc.description.abstractWe conducted a multicentre hospital-based test-negative case-control study to measure vaccine effectiveness (VE) against PCR-confirmed influenza in adult patients with severe acute respiratory infection (SARI) during the 2022/2023 influenza season in Europe. Among 5547 SARI patients ≥18 years, 2963 (53%) were vaccinated against influenza. Overall VE against influenza A(H1N1)pdm09 was 11% (95% CI: -23-36); 20% (95% CI: -4-39) against A(H3N2) and 56% (95% CI: 22-75) against B. During the 2022/2023 season, while VE against hospitalisation with influenza B was >55%, it was ≤20% for influenza A subtypes. While influenza vaccination should be a priority for future seasons, improved vaccines against influenza are needed.es_ES
dc.description.peerreviewedSíes_ES
dc.description.sponsorshipThe Hungarian study team works as part of the National Labora-tory for Health Security Hungary (RRF-2.3.1-21-2022-00006) supported by the National Research, Development and Innovation Office (NKFIH).es_ES
dc.format.number2es_ES
dc.format.pagee13255es_ES
dc.format.volume18es_ES
dc.identifier.citationInfluenza Other Respir Viruses. 2024 Feb;18(2):e13255.es_ES
dc.identifier.doi10.1111/irv.13255es_ES
dc.identifier.e-issn1750-2659es_ES
dc.identifier.journalInfluenza and other respiratory viruseses_ES
dc.identifier.pubmedID38403302es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/19060
dc.language.isoenges_ES
dc.publisherWiley
dc.relation.publisherversionhttps://doi.org/10.1111/irv.13255es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshInfluenza, Humanes_ES
dc.subject.meshInfluenza A Virus, H1N1 Subtypees_ES
dc.subject.meshInfluenza Vaccineses_ES
dc.subject.meshPneumoniaes_ES
dc.subject.meshAdultes_ES
dc.subject.meshHumanses_ES
dc.subject.meshSeasonses_ES
dc.subject.meshInfluenza A Virus, H3N2 Subtypees_ES
dc.subject.meshCase-Control Studieses_ES
dc.subject.meshVaccine Efficacyes_ES
dc.subject.meshEuropees_ES
dc.subject.meshHospitalizationes_ES
dc.subject.meshHospitalses_ES
dc.subject.meshVaccinationes_ES
dc.titleVaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital networkes_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication5611ffc3-de88-4908-b20a-9a15a58c060a
relation.isAuthorOfPublicatione177bf8c-3734-480b-a2ae-4ae67491776c
relation.isAuthorOfPublication7ac13a7f-3d30-4846-8b51-b7505c7df45c
relation.isAuthorOfPublication.latestForDiscovery5611ffc3-de88-4908-b20a-9a15a58c060a
relation.isFunderOfPublicationfa9033a8-b08f-4af2-80f9-cb96c76322dc
relation.isFunderOfPublication.latestForDiscoveryfa9033a8-b08f-4af2-80f9-cb96c76322dc
relation.isPublisherOfPublicationd81e762a-95f7-4917-88a1-8004b3b8caa7
relation.isPublisherOfPublication.latestForDiscoveryd81e762a-95f7-4917-88a1-8004b3b8caa7

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
VaccineEffectivenessAgainstInfluenza_2024.pdf
Size:
1.41 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Centro Nacional de Epidemiología (CNE)
Centro Nacional de Microbiología (CNM)
IdiSNA - Instituto de Investigación Sanitaria de Navarra (Navarra)